Description:

E5103 Non-Protocol Therapy Form [Form No. 2814v2] NCT00433511 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFF315-4D41-593F-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFF315-4D41-593F-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/18/15
Uploaded on:

June 18, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E5103 Non-Protocol Therapy Form NCT00433511

Instructions: Use this form to capture the FIRST occurrence of non-protocol anti-tumor therapy per registration step ONLY if patient's disease is still stable or in partial or complete remission and has not progressed/relapsed from protocol therapy.

ECOG clinical trial administrative data
Reporting Period
Patient demographics
Data amendment
Non-Protocol Therapy
Non-Protocol Chemotherapy
Non-Protocol Hormonal Therapy?
Non-Protocol Immunotherapy? (/Biological Response Modifiers)
Non-protocol high dose chemotherapy/stem cell transplant (Autologous or Allogeneic)
Non-Protocol Surgery
Non-Protocol Radiation Therapy?
Other Non-Protocol Therapy
Was the non-protocol therapy given for the disease of this protocol (NOTE: Treatment for a second primary in the same organ site would not be considered therapy for disease of this protocol. - NOTE: Submit ECOG Second Primary Form if applicable.)
Comments

Similar models